Pharmacoinformatic Screening of Natural Compounds to Identify Potential GPER1 Inhibitors

Key Points

ZINC39470612 and ZINC72326045 show better binding affinities than known drugs, highlighting their potential.
Binding affinities and ADME features were critical for distinguishing these compounds from existing inhibitors.
In silico analysis provided valuable insights into the structural interactions of these natural compounds with GPER1.
These findings support further exploration of natural compounds as therapeutic agents against GPER1-related conditions.

Abstract

Extensive analyses have demonstrated that ZINC39470612 and ZINC72326045 are identified as potential compounds for targeting GPER1. These compounds also exhibited better binding affinities and ADME features than reported drugs and inhibitors. These in silico findings provide critical structural and functional insights with promising therapeutic relevance.

Bookmark

Pharmacoinformatic Screening of Natural Compounds to Identify Potential GPER1 Inhibitors

Key Points

Abstract

Cite This Study